194 related articles for article (PubMed ID: 33993220)
1. PD-1 blockade prevents the progression of oral carcinogenesis.
Dong Y; Wang Z; Mao F; Cai L; Dan H; Jiang L; Zeng X; Li T; Zhou Y; Chen Q
Carcinogenesis; 2021 Jun; 42(6):891-902. PubMed ID: 33993220
[TBL] [Abstract][Full Text] [Related]
2. CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma.
Stasikowska-Kanicka O; WÄ…growska-Danilewicz M; Danilewicz M
APMIS; 2018 Sep; 126(9):732-738. PubMed ID: 30160018
[TBL] [Abstract][Full Text] [Related]
3. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
[TBL] [Abstract][Full Text] [Related]
4. T cells are involved in the induction of macrophage phenotypes in oral leukoplakia and squamous cell carcinoma-a preliminary report.
Stasikowska-Kanicka O; WÄ…growska-Danilewicz M; Danilewicz M
J Oral Pathol Med; 2018 Feb; 47(2):136-143. PubMed ID: 29108105
[TBL] [Abstract][Full Text] [Related]
5. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
[TBL] [Abstract][Full Text] [Related]
6. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
[TBL] [Abstract][Full Text] [Related]
7. PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.
Wang J; Xie T; Wang B; William WN; Heymach JV; El-Naggar AK; Myers JN; Caulin C
Cancer Prev Res (Phila); 2017 Dec; 10(12):684-693. PubMed ID: 29018057
[TBL] [Abstract][Full Text] [Related]
8. Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma.
Monteiro de Oliveira Novaes JA; Hirz T; Guijarro I; Nilsson M; Pisegna MA; Poteete A; Barsoumian HB; Fradette JJ; Chen LN; Gibbons DL; Tian X; Wang J; Myers JN; McArthur MJ; Bell D; William WN; Heymach JV
Cancer Prev Res (Phila); 2021 Mar; 14(3):313-324. PubMed ID: 33277316
[TBL] [Abstract][Full Text] [Related]
9. Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model.
Shi Y; Xie TX; Leach DG; Wang B; Young S; Osman AA; Sikora AG; Ren X; Hartgerink JD; Myers JN; Rangel R
Cancer Prev Res (Phila); 2021 Aug; 14(8):767-778. PubMed ID: 34021022
[TBL] [Abstract][Full Text] [Related]
10. Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients.
Kouketsu A; Sato I; Oikawa M; Shimizu Y; Saito H; Takahashi T; Kumamoto H
J Craniomaxillofac Surg; 2019 Jan; 47(1):33-40. PubMed ID: 30466788
[TBL] [Abstract][Full Text] [Related]
11. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
12. Expressions of Interleukin-27 in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma.
Wang QM; Huang XY; Guan WQ
Inflammation; 2022 Jun; 45(3):1023-1038. PubMed ID: 35064378
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma.
Lin L; Wang J; Liu D; Liu S; Xu H; Ji N; Zhou M; Zeng X; Zhang D; Li J; Chen Q
Sci Rep; 2016 May; 6():26757. PubMed ID: 27225603
[TBL] [Abstract][Full Text] [Related]
14. Correlation of PD-1 and PD-L1 expression in oral leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
Greeshma LR; Joseph AP; Sivakumar TT; Raghavan Pillai V; Vijayakumar G
Sci Rep; 2023 Dec; 13(1):21698. PubMed ID: 38066025
[TBL] [Abstract][Full Text] [Related]
15. A novel humanized anti-PD-1 monoclonal antibody potentiates therapy in oral squamous cell carcinoma.
Cai Y; Wang F; Liu Q; Li Z; Li D; Sun Z
Invest New Drugs; 2019 Oct; 37(5):799-809. PubMed ID: 30368626
[TBL] [Abstract][Full Text] [Related]
16. Regorafenib enhances antitumor immune efficacy of anti-PD-L1 immunotherapy on oral squamous cell carcinoma.
Chiang IT; Lee YH; Tan ZL; Hsu FT; Tu HF
Biomed Pharmacother; 2022 Mar; 147():112661. PubMed ID: 35092865
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell-exosome-mediated matrix metalloproteinase 1 participates in oral leukoplakia and carcinogenesis by inducing angiogenesis.
Li S; Han Y; Lu M; Liu Z; Jin J; Guo Q; Wang Y; Liu H
J Oral Pathol Med; 2022 Aug; 51(7):638-648. PubMed ID: 35792829
[TBL] [Abstract][Full Text] [Related]
18. Targeting IL-17alpha to promote anti-PD-1 therapy effect by screening the tumor immune microenvironment in a mouse oral carcinogenesis model.
Wang S; Yu X; Li F; Fan H; Zhao E; Hu Z
Cancer Biomark; 2021; 31(4):339-350. PubMed ID: 33896829
[TBL] [Abstract][Full Text] [Related]
19. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer.
Saintigny P; William WN; Foy JP; Papadimitrakopoulou V; Lang W; Zhang L; Fan YH; Feng L; Kim ES; El-Naggar AK; Lee JJ; Mao L; Hong WK; Lingen MW; Lippman SM
J Natl Cancer Inst; 2018 Mar; 110(3):250-7. PubMed ID: 29617836
[TBL] [Abstract][Full Text] [Related]
20. Expressions of CXCR7/ligands may be involved in oral carcinogenesis.
Xia J; Wang J; Chen N; Dai Y; Hong Y; Chen X; Cheng B
J Mol Histol; 2011 Apr; 42(2):175-80. PubMed ID: 21442287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]